Longevity extension of worker honey bees (Apis mellifera) by royal jelly: optimal dose and active ingredient

door Yang, Wenchao, Tian, Yuanyuan, Han, Mingfeng, Miao, Xiaoqing
Gepubliceerd in PeerJ (2017)

Anti-hypertensive and cardioprotective effects of a novel apitherapy formulation via upregulation of peroxisome proliferator-activated receptor-α and -γ in spontaneous hypertensive...

door Sun, Yanru, Han, Mingfeng, Shen, Zhenhuang, Huang, Haibo, Miao, Xiaoqing
Gepubliceerd in Saudi J Biol Sci (2018)

A Study on the Predictors of Disease Severity of COVID-19

door Li, Liang, Sun, Wei, Han, Mingfeng, Ying, Yunli, Wang, Quanzhi
Gepubliceerd in Med Sci Monit (2020)

Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19

door Zha, Lei, Shen, Ya, Pan, Lingling, Han, Mingfeng, Yang, Gang, Teng, Xiaobao, Tefsen, Boris
Gepubliceerd in J Infect (2021)

Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67

door Cui, Minhu, Jin, Mingji, Han, Mingfeng, Zang, Yingda, Li, Chuangjun, Zhang, Dongming, Huang, Wei, Gao, Zhonggao, Yin, Xuezhe
Gepubliceerd in Int J Nanomedicine (2020)

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19

door Gao, Yong, Li, Tuantuan, Han, Mingfeng, Li, Xiuyong, Wu, Dong, Xu, Yuanhong, Zhu, Yulin, Liu, Yan, Wang, Xiaowu, Wang, Linding
Gepubliceerd in J Med Virol (2020)

COVID-19 induced liver function abnormality associates with age

door Li, Shasha, Li, Jinsong, Zhang, Zhenhua, Tan, Lin, Shao, Tuo, Li, Ming, Li, Xiuyong, Holmes, Jacinta A., Lin, Wenyu, Han, Mingfeng
Gepubliceerd in Aging (Albany NY) (2020)

Improving anti-tumor outcomes for colorectal cancer therapy through in situ thermosensitive gel loading harmine

door Li, Zhenzhen, Chen, Liqing, He, Chenghui, Han, Ying, Han, Mingfeng, Zhang, Yingying, Qi, Lingling, Xing, Xuezhong, Huang, Wei, Gao, Zhonggao, Xing, Jianguo
Gepubliceerd in Am J Transl Res (2020)

Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China

door Wang, Ruirui, Pan, Min, Zhang, Xiumei, Han, Mingfeng, Fan, Xiaoyun, Zhao, Fengde, Miao, Manli, Xu, Jing, Guan, Minglong, Deng, Xia, Chen, Xu, Shen, Leilei
Gepubliceerd in Int J Infect Dis (2020)

Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study

door Zheng, Xueying, Luo, Sihui, Sun, Yong, Han, Mingfeng, Liu, Jian, Sun, Liangye, Zhang, Liangming, Ling, Ping, Ding, Yu, Jin, Tengchuan, Liu, Zhirong, Weng, Jianping
Gepubliceerd in Natl Sci Rev (2020)

Effective treatment of severe COVID-19 patients with tocilizumab

door Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Gepubliceerd in Proc Natl Acad Sci U S A (2020)

Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference

door Zhang, Yafei, Wang, Changtai, Han, Mingfeng, Ye, Jun, Gao, Yong, Liu, Zhongping, He, Tengfei, Li, Tuantuan, Xu, Mengyuan, Zhou, Luping, Zou, Guizhou, Lu, Mengji, Zhang, Zhenhua
Gepubliceerd in Virol Sin (2020)

Correction to: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference

door Zhang, Yafei, Wang, Changtai, Han, Mingfeng, Ye, Jun, Gao, Yong, Liu, Zhongping, He, Tengfei, Li, Tuantuan, Xu, Mengyuan, Zhou, Luping, Zou, Guizhou, Lu, Mengji, Zhang, Zhenhua
Gepubliceerd in Virol Sin (2020)

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention

door Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Gepubliceerd in Proc Natl Acad Sci U S A (2020)

Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients

door Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Gepubliceerd in Proc Natl Acad Sci U S A (2020)

Differentially expressed immune response genes in COVID-19 patients based on disease severity

door Li, Shasha, Duan, Xiaoqiong, Li, Yujia, Li, Ming, Gao, Yong, Li, Tuantuan, Li, Shilin, Tan, Lin, Shao, Tuo, Jeyarajan, Andre J., Chen, Limin, Han, Mingfeng, Lin, Wenyu, Li, Xiuyong
Gepubliceerd in Aging (Albany NY) (2021)

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial

door Hu, Ke, Guan, Wei-jie, Bi, Ying, Zhang, Wei, Li, Lanjuan, Zhang, Boli, Liu, Qingquan, Song, Yuanlin, Li, Xingwang, Duan, Zhongping, Zheng, Qingshan, Yang, Zifeng, Liang, Jingyi, Han, Mingfeng, Ruan, Lianguo, Wu, Chaomin, Zhang, Yunting, Jia, Zhen-hua, Zhong, Nan-shan
Gepubliceerd in Phytomedicine (2021)

Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity

door Han, Mingfeng, Xu, Mengyuan, Zhang, Yafei, Liu, Zhongping, Li, Shasha, He, Tengfei, Li, Jinsong, Gao, Yong, Liu, Wanjun, Li, Tuantuan, Chen, Zixiang, Huang, Xin, Cheng, Guoling, Wang, Jun, Dittmer, Ulf, Witzke, Oliver, Zou, Guizhou, Li, Xiuyong, Lu, Mengji, Zhang, Zhenhua
Gepubliceerd in Med Microbiol Immunol (2020)

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

door Tang, Wei, Cao, Zhujun, Han, Mingfeng, Wang, Zhengyan, Chen, Junwen, Sun, Wenjin, Wu, Yaojie, Xiao, Wei, Liu, Shengyong, Chen, Erzhen, Chen, Wei, Wang, Xiongbiao, Yang, Jiuyong, Lin, Jun, Zhao, Qingxia, Yan, Youqin, Xie, Zhibin, Li, Dan, Yang, Yaofeng, Liu, Leshan, Qu, Jieming, Ning, Guang, Shi, Guochao, Xie, Qing
Gepubliceerd in BMJ (2020)

Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial

door Wang, Dongsheng, Fu, Binqing, Peng, Zhen, Yang, Dongliang, Han, Mingfeng, Li, Min, Yang, Yun, Yang, Tianjun, Sun, Liangye, Li, Wei, Shi, Wei, Yao, Xin, Ma, Yan, Xu, Fei, Wang, Xiaojing, Chen, Jun, Xia, Daqing, Sun, Yubei, Dong, Lin, Wang, Jumei, Zhu, Xiaoyu, Zhang, Min, Zhou, Yonggang, Pan, Aijun, Hu, Xiaowen, Mei, Xiaodong, Wei, Haiming, Xu, Xiaoling
Gepubliceerd in Front Med (2021)